Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2023 – 2026. Sell or Buy?
Last update: May 11, 2023 (18:47)
Sector: HealthcareThe share price of Alnylam Pharmaceuticals, Inc. (ALNY) now
50/200 Day Moving Average: $194.28 / $204.72
This figure corresponds to the Average Price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Alnylam Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Alnylam Pharmaceuticals share be worth in 2023 - 2027?
When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Alnylam Pharmaceuticals stock
The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Alnylam Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 29 | 129.75 | 127.62 | 130.42 | 2.19 |
| May 30 | 130.32 | 128.56 | 131.00 | 1.90 |
| May 31 | 129.31 | 128.20 | 130.75 | 1.99 |
| Jun 01 | 125.94 | 123.72 | 127.12 | 2.75 |
| Jun 02 | 128.40 | 125.73 | 129.43 | 2.95 |
| Jun 03 | 127.80 | 126.04 | 129.49 | 2.74 |
| Jun 04 | 127.27 | 125.68 | 129.52 | 3.05 |
| Jun 05 | 125.65 | 123.95 | 127.51 | 2.87 |
| Jun 06 | 127.77 | 126.67 | 129.33 | 2.10 |
| Jun 07 | 128.93 | 126.32 | 131.21 | 3.88 |
| Jun 08 | 130.47 | 129.12 | 133.09 | 3.07 |
| Jun 09 | 133.09 | 131.87 | 133.95 | 1.57 |
| Jun 10 | 134.40 | 132.27 | 135.69 | 2.59 |
| Jun 11 | 133.81 | 132.07 | 135.58 | 2.66 |
| Jun 12 | 133.63 | 131.27 | 135.96 | 3.57 |
| Jun 13 | 137.11 | 135.11 | 138.21 | 2.30 |
| Jun 14 | 136.00 | 133.17 | 137.81 | 3.48 |
| Jun 15 | 135.75 | 134.55 | 136.85 | 1.70 |
| Jun 16 | 135.61 | 132.93 | 137.59 | 3.50 |
| Jun 17 | 133.50 | 132.80 | 135.48 | 2.01 |
| Jun 18 | 134.96 | 132.67 | 137.20 | 3.41 |
| Jun 19 | 136.71 | 134.79 | 139.16 | 3.24 |
| Jun 20 | 139.87 | 137.65 | 141.51 | 2.80 |
| Jun 21 | 141.58 | 138.90 | 142.83 | 2.84 |
| Jun 22 | 140.88 | 138.80 | 143.52 | 3.40 |
| Jun 23 | 140.92 | 138.72 | 141.73 | 2.17 |
| Jun 24 | 142.31 | 139.98 | 144.53 | 3.25 |
| Jun 25 | 141.94 | 139.80 | 142.68 | 2.06 |
| Jun 26 | 142.98 | 140.52 | 145.43 | 3.49 |
| Jun 27 | 141.82 | 139.46 | 143.41 | 2.83 |
Alnylam Pharmaceuticals Daily Price Targets
Alnylam Pharmaceuticals Stock Forecast 05-29-2022.
Forecast target price for 05-29-2022: $129.75.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.147%.
Pessimistic target level: 127.62
Optimistic target level: 130.42
Alnylam Pharmaceuticals Stock Forecast 05-30-2022.
Forecast target price for 05-30-2022: $130.32.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.863%.
Pessimistic target level: 128.56
Optimistic target level: 131.00
Alnylam Pharmaceuticals Stock Forecast 05-31-2022.
Forecast target price for 05-31-2022: $129.31.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.955%.
Pessimistic target level: 128.20
Optimistic target level: 130.75
Alnylam Pharmaceuticals Stock Forecast 06-01-2022.
Forecast target price for 06-01-2022: $125.94.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.679%.
Pessimistic target level: 123.72
Optimistic target level: 127.12
Alnylam Pharmaceuticals Stock Forecast 06-02-2022.
Forecast target price for 06-02-2022: $128.40.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.863%.
Pessimistic target level: 125.73
Optimistic target level: 129.43
Alnylam Pharmaceuticals Stock Forecast 06-03-2022.
Forecast target price for 06-03-2022: $127.80.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.669%.
Pessimistic target level: 126.04
Optimistic target level: 129.49
ALNY (ALNY) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 188.27 | 178.33 | 197.18 | 9.56 |
| Nov. | 181.23 | 176.85 | 186.61 | 5.23 |
| Dec. | 176.05 | 160.56 | 182.83 | 12.18 |
Alnylam Pharmaceuticals forecast for this year
Alnylam Pharmaceuticals Stock Prediction for Oct 2023
An uptrend is forecast for this month with an optimal target price of $188.273. Pessimistic: $178.33. Optimistic: $197.18
Alnylam Pharmaceuticals Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $181.232. Pessimistic: $176.85. Optimistic: $186.61
Alnylam Pharmaceuticals Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $176.048. Pessimistic: $160.56. Optimistic: $182.83
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 178.18 | 165.05 | 182.49 | 9.56 |
| Feb | 185.82 | 177.24 | 200.74 | 11.71 |
| Mar | 180.10 | 168.21 | 188.22 | 10.63 |
| Apr | 199.12 | 191.89 | 213.57 | 10.15 |
| May | 190.58 | 181.35 | 205.88 | 11.91 |
| Jun | 192.25 | 176.39 | 202.83 | 13.03 |
| Jul | 209.38 | 199.71 | 218.60 | 8.64 |
| Aug | 216.52 | 211.52 | 228.19 | 7.31 |
| Sep | 211.76 | 200.11 | 221.54 | 9.67 |
| Oct | 210.59 | 192.29 | 226.35 | 15.05 |
| Nov | 215.46 | 203.37 | 233.71 | 12.98 |
| Dec | 212.85 | 198.80 | 225.50 | 11.84 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 203.02 | 187.83 | 213.74 | 12.12 |
| Feb | 206.59 | 196.59 | 214.09 | 8.17 |
| Mar | 224.32 | 214.69 | 232.95 | 7.84 |
| Apr | 231.47 | 223.83 | 249.55 | 10.30 |
| May | 217.72 | 206.71 | 225.87 | 8.48 |
| Jun | 200.48 | 195.85 | 214.37 | 8.64 |
| Jul | 201.14 | 188.53 | 206.89 | 8.88 |
| Aug | 199.59 | 192.13 | 210.13 | 8.57 |
| Sep | 215.62 | 198.54 | 231.99 | 14.42 |
| Oct | 222.74 | 211.95 | 229.60 | 7.68 |
| Nov | 223.23 | 205.79 | 229.85 | 10.47 |
| Dec | 230.35 | 218.94 | 241.24 | 9.24 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 230.09 | 223.26 | 236.17 | 5.47 |
| Feb | 226.55 | 207.36 | 241.50 | 14.14 |
| Mar | 212.34 | 206.27 | 227.53 | 9.34 |
| Apr | 213.75 | 206.22 | 221.98 | 7.10 |
| May | 222.68 | 213.86 | 232.48 | 8.01 |
| Jun | 230.27 | 218.12 | 241.42 | 9.65 |
| Jul | 238.38 | 231.30 | 245.98 | 5.97 |
| Aug | 237.59 | 230.28 | 256.93 | 10.38 |
| Sep | 239.42 | 233.37 | 253.64 | 8.00 |
| Oct | 238.11 | 219.25 | 251.20 | 12.72 |
| Nov | 254.87 | 240.57 | 269.17 | 10.62 |
| Dec | 262.16 | 248.60 | 268.79 | 7.51 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 275.42 | 257.85 | 288.15 | 10.51 |
| Feb | 249.97 | 239.52 | 271.70 | 11.84 |
| Mar | 246.67 | 235.28 | 259.43 | 9.31 |
| Apr | 256.44 | 249.95 | 278.45 | 10.23 |
| May | 256.16 | 235.31 | 276.45 | 14.88 |
| Jun | 256.72 | 235.26 | 275.36 | 14.56 |
| Jul | 274.23 | 253.42 | 298.06 | 14.98 |
| Aug | 266.09 | 259.94 | 282.19 | 7.88 |
| Sep | 276.92 | 267.17 | 290.93 | 8.17 |
| Oct | 295.50 | 276.32 | 313.05 | 11.73 |
| Nov | 327.68 | 309.66 | 353.99 | 12.52 |
| Dec | 336.69 | 328.91 | 345.58 | 4.82 |
Alnylam Pharmaceuticals information and performance
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
